Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy

Fig. 1

Number of anti-citrullinated protein antibody (ACPA) reactivities according to autoantibody status. a All patients with rheumatoid arthritis (RA). b Controls. c Patients with anti-cyclic citrullinated peptide (anti-CCP)+ RA. d Patients with anti-CCP- RA. e Patients with rheumatoid factor (RF)+ RA. f Patients with RF- RA. g Patients with anti-CCP+/RF+ RA. h Patients with anti-CCP-/RF- RA

Back to article page